Both ASTELIN and Nasonex were well tolerated in the study.
氮卓斯汀喷雾剂和内舒拿在研究中均耐受良好。
2
This significant difference in symptom reduction for ASTELIN persisted at each time point during the 8-hour allergen exposure versus placebo.
氮卓斯汀喷雾剂在8小时变应原暴露期间任一时间点与安慰剂组比较持续减轻症状，有显著差异性。
3
Because ASTELIN is a product in a highly competitive therapeutic category where fast relief is important, an established rapid onset of action gives ASTELIN the hallmark of a potential market leader.